Immunic (IMUX) Capital Expenditures Growth (3y) (2016 - 2026)
Immunic (IMUX) Capital Expenditures Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Immunic |
384.84 Mn |
198.21 Mn |
- |
-73.21% |
| Date | Value |
|---|
| Mar 31, 2026 |
-73.21% |
| Dec 31, 2025 |
135.13% |
| Sep 30, 2025 |
-2.82% |
| Jun 30, 2025 |
8.74% |
| Mar 31, 2025 |
57.63% |
| Dec 31, 2024 |
-45.95% |
| Sep 30, 2024 |
35.72% |
| Jun 30, 2024 |
115.44% |
| Mar 31, 2024 |
45.81% |
| Dec 31, 2023 |
90.15% |
| Sep 30, 2023 |
-11.28% |
| Jun 30, 2023 |
-27.45% |
| Mar 31, 2023 |
196.25% |
| Dec 31, 2022 |
-26.83% |
| Sep 30, 2022 |
77.74% |
| Jun 30, 2022 |
40.95% |
| Mar 31, 2022 |
19.68% |
| Dec 31, 2021 |
-1.70% |
| Sep 30, 2021 |
58.74% |
| Jun 30, 2021 |
28.58% |
